WHO ICTRP trial
EFFECTIVENESS AND TOLERABILITY OF TREATMENT WITH CABERGOLINE IN PATIENTS WITH…
EUCTR2006-005218-11-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2006-005218-11-IT |
|---|---|
| Public title | EFFECTIVENESS AND TOLERABILITY OF TREATMENT WITH CABERGOLINE IN PATIENTS WITH CUSHING S SYNDROME - CABERGOLINE IN CUSHING S SYNDROME |
| Scientific title | EFFECTIVENESS AND TOLERABILITY OF TREATMENT WITH CABERGOLINE IN PATIENTS WITH CUSHING S SYNDROME - CABERGOLINE IN CUSHING S SYNDROME |
| Primary sponsor | ASSOCIAZIONE ITALIANA ENDOCRINOLOGIA-METABOLISMO-IPOFISI |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | Cushing syndrome MedDRA version: 9.1 Level: LLT Classification code 10011652 Term: Cushing's syndrome |
| Interventions | Trade Name: DOSTINEX Pharmaceutical Form: Tablet Concentration unit: mg milligram(s) Concentration type: equal Concentration number: .5- Trade Name: NIZORAL Pharmaceutical Form: Tablet Concentration unit: mg milligram(s) Concentration type… |
| Registration date | Mar 4, 2007 |
| Secondary IDs | FARM58SK29 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: